Xianwang Liu Selected Research

Drug Therapy (Chemotherapy)

3/2023

Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianwang Liu Research Topics

Disease

9	Neoplasms (Cancer) 05/2024 - 01/2021
3	Meningioma (Meningiomas) 04/2024 - 10/2023
2	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2023
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 03/2023
1	Stomach Neoplasms (Stomach Cancer) 05/2024
1	Astrocytoma (Pilocytic Astrocytoma) 04/2024
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2024
1	Neurilemmoma (Schwannoma) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Ascites 11/2021
1	Lymphoma (Lymphomas) 08/2021
1	Glioma (Gliomas) 01/2021

Drug/Important Bio-Agent (IBA)

5	IodineIBA 05/2024 - 11/2021
3	N-acetoacetyl-N-deacetylcolchicineIBA 04/2024 - 01/2021
2	Bevacizumab (Avastin)FDA Link 03/2023 - 01/2021
1	Carcinoembryonic AntigenIBA 05/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	A 7 (A-7)IBA 10/2023
1	AntigensIBA 12/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021

Therapy/Procedure

1	Patient Readmission 03/2024
1	Therapeutics 03/2024
1	Aftercare (After-Treatment) 11/2023
1	Drug Therapy (Chemotherapy) 03/2023
1	Radiotherapy 01/2023